Matthew W. Decamp

Matthew Decamp practices at Cu Medicine in Denver, Colorado.

Matthew Decamp's NPI, 1215190848, was assigned on July 3, 2008. Matthew Decamp graduated from Duke University School of Medicine in 2008. Matthew Decamp holds Colorado license DR.0061527.

Matthew Decamp's primary practice is Cu Medicine, at 2000 S Colorado Blvd, Denver, CO 80222 in Denver County. The practice phone is (303) 493-7000.

Matthew Decamp's primary practice is Cu Medicine in Denver, Colorado. Matthew Decamp is also affiliated with UCHealth University of Colorado Hospital. The medical group on file is University of Colorado Medicine (CU Medicine). Dmand AI also links Matthew Decamp to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Matthew Decamp practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Matthew Decamp's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Matthew Decamp is licensed in Colorado.

CMS data shows 146 Medicare services from Matthew Decamp across 4 procedure codes in 2024, for 65 Medicare patients. Medicare paid $5,512 for them. Every service was in an office.

CMS counts 65 Medicare patients who saw Matthew Decamp in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have high cholesterol, and 62% have high blood pressure. Their average risk score is 0.76, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Matthew Decamp's median patient age at 69, with 27% women.

In 2024, Matthew Decamp wrote 789 Medicare Part D claims for 88 patients. 89% of them were for generic drugs. CMS names the drug for 437 of them, across 19 drugs with 11 or more claims each, at $38,400 in total drug cost. In 2023, CMS named 374 claims across 20 drugs.

Matthew Decamp accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Matthew Decamp as offering telehealth.

Dmand AI links 88 papers to Matthew Decamp, published from 2013 to 2025. 2023 was the busiest year, with 9. The most frequent topics are Physicians, Global Health and Ethics, Medical. Matthew Decamp has published most often in J Gen Intern Med. Matthew Decamp's most frequent co-authors are Hillary Day Lum, MD, PhD, Elizabeth Riley Kessler, MD and Vinay Kini, MD.

CMS Open Payments shows 3 general payments to Matthew Decamp from 2 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 99% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $2,646.

Matthew Decamp graduated from Duke University School of Medicine in 2008.